Helen Pearson

4.2k total citations · 1 hit paper
130 papers, 2.9k citations indexed

About

Helen Pearson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helen Pearson has authored 130 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helen Pearson's work include Wnt/β-catenin signaling in development and cancer (10 papers), Science, Research, and Medicine (8 papers) and Prostate Cancer Treatment and Research (8 papers). Helen Pearson is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (10 papers), Science, Research, and Medicine (8 papers) and Prostate Cancer Treatment and Research (8 papers). Helen Pearson collaborates with scholars based in Australia, United Kingdom and United States. Helen Pearson's co-authors include Boris Shorning, Matthew J. Smalley, Patrick O. Humbert, Toby J. Phesse, Alan R. Clarke, Wayne A. Phillips, Ygal Haupt, Carleen Cullinane, Daniel Kelly and Karen G. Montgomery and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Helen Pearson

102 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling

2020 412 citations Matthew J. Smalley, Helen Pearson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Pearson Australia	31	1.5k	601	559	525	324	130	2.9k
Simone Chevalier Canada	29	1.5k 1.0×	497 0.8×	710 1.3×	445 0.8×	257 0.8×	119	2.9k
Xiaohua Yan China	30	2.1k 1.4×	487 0.8×	360 0.6×	588 1.1×	202 0.6×	79	3.4k
David A. Potter United States	25	1.2k 0.8×	622 1.0×	447 0.8×	249 0.5×	570 1.8×	63	2.5k
Céline Lefèbvre France	29	2.6k 1.7×	675 1.1×	548 1.0×	643 1.2×	172 0.5×	54	3.8k
Alessandro Datti Canada	36	2.7k 1.8×	812 1.4×	272 0.5×	618 1.2×	339 1.0×	97	4.1k
Yihang Pan China	27	1.5k 1.0×	693 1.2×	420 0.8×	446 0.8×	188 0.6×	86	3.5k
Shing Chuan Hooi Singapore	30	1.8k 1.2×	523 0.9×	257 0.5×	722 1.4×	200 0.6×	65	2.9k
Sen Chen China	28	1.7k 1.1×	584 1.0×	1.2k 2.2×	763 1.5×	239 0.7×	105	3.8k
Wenjuan Wang China	38	1.9k 1.2×	971 1.6×	326 0.6×	778 1.5×	320 1.0×	154	3.5k
Sibaji Sarkar United States	19	2.5k 1.6×	1.1k 1.9×	320 0.6×	818 1.6×	205 0.6×	47	4.0k

Countries citing papers authored by Helen Pearson

Since Specialization

Citations

This map shows the geographic impact of Helen Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Pearson more than expected).

Fields of papers citing papers by Helen Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Pearson. The network helps show where Helen Pearson may publish in the future.

Co-authorship network of co-authors of Helen Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Pearson. A scholar is included among the top collaborators of Helen Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Pearson. Helen Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pearson, Helen & Heidi Ledford. (2025). Trump links autism and Tylenol: is there any truth to it?. Nature. 646(8083). 13–14.

Pearson, Helen. (2025). Alcohol and cancer risk: what you need to know. Nature. 639(8054). 290–292.

Fisher, Matthew, Mateus Crespo, Bora Gürel, et al.. (2024). Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009368–e009368. 7 indexed citations

Bullock, Nicholas, Kathryn Gilroy, Radhika A. Patel, et al.. (2024). Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer. Cells. 13(8). 673–673. 1 indexed citations

Pearson, Helen. (2024). What’s the best way to tackle climate change? An ‘evidence bank’ could help scientists find answers. Nature. 630(8017). 540–541. 2 indexed citations

Flanagan, Dustin J., Nick Barker, Elizabeth A. Mason, et al.. (2019). Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations. Cancer Research. 79(5). 970–981. 84 indexed citations

Pearson, Helen, Jason Li, Valérie S. Méniel, et al.. (2018). Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth. Cancer Discovery. 8(6). 764–779. 78 indexed citations

Liu, David S., Cuong Duong, Sue Haupt, et al.. (2017). Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation. Nature Communications. 8(1). 14844–14844. 260 indexed citations

Rebello, Richard J., Eric Kusnadi, Donald P. Cameron, et al.. (2016). The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer. Clinical Cancer Research. 22(22). 5539–5552. 61 indexed citations

10.

Rebello, Richard J., Eric Kusnadi, Donald P. Cameron, et al.. (2016). The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer. European Journal of Cancer. 61. S167–S167. 10 indexed citations

11.

Pearson, Helen, Edwina McGlinn, Toby J. Phesse, et al.. (2015). The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis. Molecular Cancer. 14(1). 169–169. 30 indexed citations

12.

Sampurno, Shienny, Ryan Cross, Helen Pearson, et al.. (2015). Myb via TGFβis required for collagen type 1 production and skin integrity. Growth Factors. 33(2). 102–112. 3 indexed citations

13.

Pase, Luke, Helen Pearson, Nathan Gödde, et al.. (2015). A Chemical Screening Approach to Identify Novel Key Mediators of Erythroid Enucleation. PLoS ONE. 10(11). e0142655–e0142655. 9 indexed citations

14.

Pearson, Helen, et al.. (2015). Fetal human airway smooth muscle cell production of leukocyte chemoattractants is differentially regulated by fluticasone. Pediatric Research. 78(6). 650–656. 6 indexed citations

15.

DiTommaso, Tia, Denny L. Cottle, Helen Pearson, et al.. (2014). Keratin 76 Is Required for Tight Junction Function and Maintenance of the Skin Barrier. PLoS Genetics. 10(10). e1004706–e1004706. 30 indexed citations

16.

Gödde, Nathan, Julie M. Sheridan, Lorey Smith, et al.. (2014). Scribble Modulates the MAPK/Fra1 Pathway to Disrupt Luminal and Ductal Integrity and Suppress Tumour Formation in the Mammary Gland. PLoS Genetics. 10(5). e1004323–e1004323. 48 indexed citations

17.

Elsum, Imogen, Laura L. Yates, Helen Pearson, et al.. (2013). Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Oncogene. 33(48). 5523–5533. 46 indexed citations

18.

Pearson, Helen, Pedro A. Pérez–Mancera, Lukas E. Dow, et al.. (2011). SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. Journal of Clinical Investigation. 121(11). 4257–4267. 143 indexed citations

19.

Pearson, Helen, Toby J. Phesse, & Alan R. Clarke. (2008). K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse. Cancer Research. 69(1). 94–101. 65 indexed citations

20.

Pearson, Helen. (2003). RNA Extraction from Tissue Sections. Humana Press eBooks. 226. 47–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact